KARVEZIDE 300/25 irbesartan 300mg and hydrochlorothiazide 25mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

karvezide 300/25 irbesartan 300mg and hydrochlorothiazide 25mg tablet blister pack

sanofi-aventis australia pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: iron oxide red; iron oxide yellow; croscarmellose sodium; silicon dioxide; carnauba wax; lactose monohydrate; microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; titanium dioxide; hypromellose; iron oxide black; macrogol 3350 - karvezide is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

KARVEZIDE 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

karvezide 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack

sanofi-aventis australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hypromellose; lactose monohydrate; silicon dioxide; croscarmellose sodium; magnesium stearate; carnauba wax; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 3000 - karvezide is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

KARVEZIDE 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

karvezide 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack

sanofi-aventis australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; carnauba wax; magnesium stearate; silicon dioxide; microcrystalline cellulose; hypromellose; lactose monohydrate; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 3000 - karvezide is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Karvid 6.25 Tablets 6.25 mg Tanzania - English - Tanzania Medicinces & Medical Devices Authority

karvid 6.25 tablets 6.25 mg

astra lifecare india ltd., india - carvedilol ep/bp - tablets - 6.25 mg

Karvezide European Union - English - EMA (European Medicines Agency)

karvezide

sanofi winthrop industrie - irbesartan, hydrochlorothiazide - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension.this fixed-dose combination is indicated in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone.

Karvezide Australia - English - Department of Health (Therapeutic Goods Administration)

karvezide

sanofi-aventis australia pty ltd - irbesartan; hydrochlorothiazide -

Karvezide New Zealand - English - Medsafe (Medicines Safety Authority)

karvezide

sanofi-aventis new zealand limited - hydrochlorothiazide 12.5mg; irbesartan 150mg;  ;  ;  ;   - film coated tablet - 150mg/12.5mg - active: hydrochlorothiazide 12.5mg irbesartan 150mg         excipient: carnauba wax colloidal silicon dioxide croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opadry pink 32f24503

Karvezide New Zealand - English - Medsafe (Medicines Safety Authority)

karvezide

sanofi-aventis new zealand limited - hydrochlorothiazide 12.5mg; irbesartan 300mg;  ;  ;  ;   - film coated tablet - 300mg/12.5mg - active: hydrochlorothiazide 12.5mg irbesartan 300mg         excipient: carnauba wax colloidal silicon dioxide croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opadry pink 32f24503